scholarly journals Profiles of instrumental, emotional, and informational support in Chinese breast cancer patients undergoing chemotherapy: a latent class analysis

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Tingting Cai ◽  
Qingmei Huang ◽  
Changrong Yuan
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Social Relationships ◽  
Short Form ◽  
Educational Background ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
Informational Support ◽  
Breast Cancer Patients ◽  
Form Analysis

Abstract Background To date, few studies have assessed social relationships in patients with breast cancer during their chemotherapy process. This study aimed to explore profiles of instrumental, emotional, and informational support in Chinese breast cancer patients undergoing chemotherapy. Methods In a cross-sectional study performed between September 2018 and September 2020 in China, 638 patients with breast cancer completed demographic information questionnaires, the PROMIS-Social Relationships Short Forms, the PROMIS-Anxiety Short Form, and the PROMIS-Depression Short Form. Analysis of variance and chi-square tests were performed to examine between-group differences in demographic characteristics, anxiety, and depression outcomes across the identified latent classes. Multinomial logistic regression was performed to identify the correlation of significant variables among the identified classes. Results Three profiles of social relationships were identified: Class 1-low social relationships group (14.3%), Class 2-high instrumental support, medium emotional and informational support group (24.6%), and Class 3-high social relationships group (61.1%). The findings revealed the heterogeneity of instrumental, emotional, and informational support in Chinese breast cancer patients undergoing chemotherapy, which was significantly correlated with educational background, monthly family income, health insurance, and employment status. Additionally, patients with low instrumental, emotional, and informational support were more likely to report high levels of anxiety and depression. Conclusions When conducting interventions to promote social relationships during the chemotherapy process, healthcare providers should consider the sociodemographic characteristics, anxiety levels, and depression symptoms of patients with breast cancer and identify high-risk patients for tailored interventions.

scholarly journals Investigation of Symptom Status, Body Perception Levels and Symptoms of Anxiety and Depression in Breast Cancer Patients Receiving Paclitaxel: A Prospective Longitudinal Study

2021 ◽  
Author(s):  
GAMZE GÖKÇE CEYLAN ◽  
Zehra GÖK METİN
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Anxiety And Depression ◽  
Depression Symptoms ◽  
Breast Cancer Patients ◽  
Body Perception ◽  
The Mean ◽  
Symptom Status ◽  
Hands And Feet ◽  
Prospective Longitudinal

Abstract Purpose: This study aimed to investigate symptom status, body perception level changes and the symptoms of anxiety and depression in breast cancer patients receiving Paclitaxel.Methods: This descriptive, and prospective study was conducted with 84 breast cancer patients receiving paclitaxel regimen. “Chemotherapy Symptom Assessment Scale (C-SAS)”, “Body Perception Scale (BPS)” and “Hospital Anxiety and Depression Scale (HADS)” were applied at five time points (T₁, T₂, T₃, T₄, T₅). Data was analyzed using descriptive statistics, Wilcoxon, Friedman, Cochrane Q and Spearman’s correlation tests.Results: The frequency of needling and numbness in hands and feet, pain, and skin or nail changes significantly increased in the subsequent assessment points (T₂, T₃, T₄, and T₅) compared to the initial assessment (T₁) (p<0.05). The mean scores of BPS significantly decreased at T₂, T₄, and T₅ (p<0.01). The mean scores of the anxiety subscale of the HADS scale decreased at the T2, T3, and T4 (p<0.01), and the mean scores of the depression subscale significantly increased at the T3, T4, and T5 (p<0.01).Conclusions: The findings underscore the need for oncology nurses to provide comprehensive training sessions on effective symptom management, changes in body perception levels, and alleviation of the symptoms of anxiety and depression in breast cancer patients receiving paclitaxel. In this way, the physiological symptom burden that occurs in patients may be alleviated, and negative changes in body perception, anxiety and depression symptoms may be decreased.

Quality of life, anxiety and depression in Turkish breast cancer patients and in their husbands

2008 ◽  
Vol 26 (4) ◽  
pp. 415-419 ◽  
Author(s):  
Ahmet Alacacioglu ◽  
Tugba Yavuzsen ◽  
Meliha Dirioz ◽  
Ugur Yilmaz
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Cancer Patients ◽  
Anxiety And Depression ◽  
Breast Cancer Patients

Anxiety and Depression in Breast Cancer Patients at Low Risk of Recurrence Compared with the General Population

1999 ◽  
Vol 52 (6) ◽  
pp. 523-530 ◽  
Author(s):  
Mogens Groenvold ◽  
Peter M Fayers ◽  
Mirjam A.G Sprangers ◽  
Jakob B Bjorner ◽  
Marianne C Klee ◽  
...  
Keyword(s):  
Breast Cancer ◽  
General Population ◽  
Cancer Patients ◽  
Low Risk ◽  
Anxiety And Depression ◽  
Breast Cancer Patients ◽  
Risk Of Recurrence

Anxiety and depression in breast cancer patients before and after participation in a cancer support group

2001 ◽  
Vol 45 (3) ◽  
pp. 195-198 ◽  
Author(s):  
Ali Montazeri ◽  
Soghra Jarvandi ◽  
Shahpar Haghighat ◽  
Mariam Vahdani ◽  
Akram Sajadian ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Support Group ◽  
Anxiety And Depression ◽  
Breast Cancer Patients ◽  
Cancer Support ◽  
Before And After ◽  
Cancer Support Group

Would women with breast cancer prefer to receive an antidepressant for anxiety or depression from their oncologist?

2015 ◽  
Vol 33 (29_suppl) ◽  
pp. 219-219
Author(s):  
Daniel Curtis McFarland ◽  
Megan Johnson Shen ◽  
Kirk Harris ◽  
Amy Tiersten ◽  
John Mandeli ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mental Health ◽  
Health Professional ◽  
Cancer Patients ◽  
Mental Health Professional ◽  
Depression Scale ◽  
Patient Treatment ◽  
Anxiety And Depression ◽  
Breast Cancer Patients ◽  
To Receive

219 Background: Patient treatment preferences for the management of anxiety and depression influence adherence and treatment outcomes, yet breast cancer patient preferences for provider-specific pharmacologic management of anxiety and depression is unknown. This study examined breast cancer patients’ antidepressant prescriber preferences and their preferences for treatment by a mental health professional. Methods: Breast cancer patients (Stage 0-IV) were asked two questions: 1) “Would you be willing to have your oncologist treat your depression or anxiety with an antidepressant medication if you were to become depressed or anxious at any point during your treatment?”; and 2) “Would you prefer to be treated by a psychiatrist or mental health professional for problems with either anxiety or depression?” Additionally, the Distress Thermometer and Problem List, Hospital Anxiety and Depression Scale, Risky Families Questionnaire, and demographic information were assessed. Results: One hundred twenty-five participants completed the study. 60.4% were willing to accept an antidepressant from an oncologist and 26.3% preferred treatment by a mental health professional. 77.3% who were willing to receive an antidepressant from their oncologist reported either no preference or that treatment by a mental health professional didn’t matter (p = 0.01). Participants taking antidepressants (p = 0.02) or reporting high chronic stress (p = 0.03) preferred a mental health professional. Conclusions: The majority of patients accepted antidepressant prescribing by their oncologist; only a minority preferred treatment by a mental health professional. These findings suggest the benefit for promoting education of oncologists to assess psychological symptoms and manage anxiety and depression as a routine part of an outpatient visit.

The Mental Adjustment to Cancer (MAC) Scale: replication and refinement in 632 breast cancer patients

1999 ◽  
Vol 29 (6) ◽  
pp. 1335-1345 ◽  
Author(s):  
R. H. OSBORNE ◽  
G. R. ELSWORTH ◽  
D. W. KISSANE ◽  
S. A. BURKE ◽  
J. L. HOPPER
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Concurrent Validity ◽  
General Structure ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Breast Cancer Patients ◽  
Hospital Anxiety ◽  
Mental Adjustment ◽  
Fighting Spirit

Background. Assessment of adjustment of patients in cancer treatment trials is becoming more common and increasingly regarded as a useful outcome measure. The widely used Mental Adjustment to Cancer (MAC) Scale was designed to measure Fighting Spirit (FS), Anxious Preoccupation (AP), Helpless–hopelessness (HH) and Fatalism.Methods. Questionnaire responses from 632 breast cancer patients were randomly divided into two groups, one for exploratory analyses and possible scale refinement, and the other for validation purposes.Results. Estimates of reliability (Cronbach's α) were satisfactory for two scales, FS (α = 0·85) and HH (α = 0·81), but lower for AP (α = 0·65) and Fatalism (α = 0·64). Exploratory factor analysis suggested that the MAC Scale might be measuring six independent constructs including two related to Fighting Spirit (Positive Orientation to the Illness, Minimizing the Illness), two related to Fatalism (Fatalism-revised, Loss of Control), a construct we have named Angst, and an unchanged HH construct. Scales developed to measure these constructs were satisfactorily replicated in confirmatory analyses but some reliabilities were lower than desirable. The general structure of the MAC Scale remained little changed despite the division of two scales and the suggested removal of six items. The refined scales correlated with the Hospital Anxiety and Depression scale and the Medical Coping Modes Questionnaire, indicating good concurrent validity.Conclusions. While reasonable reliability of the original scales persists through analyses of the MAC Scale, the original factor structure could not be reproduced. Six refined constructs with strong construct validity were identified within the overall domain of mental adjustment to cancer.

Sign in / Sign up

Export Citation Format

Share Document